The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Colorectal Cancer Screening Test Market Research Report 2025
Synopsis
A colorectal cancer screening test refers to a diagnostic procedure aimed at detecting early signs of colorectal cancer or precancerous conditions in individuals without symptoms. These screening tests include various methods such as stool-based tests, imaging tests like colonoscopy, sigmoidoscopy, and virtual colonoscopy, as well as blood tests for tumor markers. The primary goal of colorectal cancer screening is to identify abnormalities in the colon or rectum at an early stage when cancer is most treatable, allowing for timely intervention and improved patient outcomes.
The global Colorectal Cancer Screening Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for colorectal cancer screening tests is witnessing significant growth due to increasing awareness about the importance of early detection and the rising prevalence of colorectal cancer worldwide. Governments, healthcare organizations, and advocacy groups are actively promoting colorectal cancer screening programs to reduce mortality rates and healthcare costs associated with late-stage diagnoses. Stool-based tests, such as fecal occult blood tests (FOBT) and fecal immunochemical tests (FIT), are gaining popularity due to their non-invasive nature and convenience for patients. Additionally, advancements in imaging technologies and blood-based biomarkers are improving the accuracy and efficacy of colorectal cancer screening tests. However, challenges such as patient compliance, access to screening facilities, and reimbursement issues hinder market growth. Nonetheless, with ongoing research and development efforts aimed at enhancing test accuracy, expanding screening programs, and improving patient awareness, the colorectal cancer screening test market is expected to continue growing, particularly in regions with aging populations and increasing healthcare infrastructure.
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Screening Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Screening Test.
Report Scope
The Colorectal Cancer Screening Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colorectal Cancer Screening Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Screening Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novigenix SA
Eiken Chemical Co., Ltd.
Clinical Genomics Pathology, Inc.
Exact Sciences Corporation
Epigenomics AG
BioMerieux S.A.
Olympus Corporation
Sysmex Corporation
Fujifilm Holdings Corporation
Siemens Healthineers AG (Siemens AG)
Segment by Type
Fecal Immunochemical Test (FIT)
Fecal Occult Blood Test (FOBT)
Stool-DNA Test
Other
Segment by Application
Hospitals & Clinics
Clinical Laboratories
Diagnostic Imaging Centres
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Screening Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A colorectal cancer screening test refers to a diagnostic procedure aimed at detecting early signs of colorectal cancer or precancerous conditions in individuals without symptoms. These screening tests include various methods such as stool-based tests, imaging tests like colonoscopy, sigmoidoscopy, and virtual colonoscopy, as well as blood tests for tumor markers. The primary goal of colorectal cancer screening is to identify abnormalities in the colon or rectum at an early stage when cancer is most treatable, allowing for timely intervention and improved patient outcomes.
The global Colorectal Cancer Screening Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for colorectal cancer screening tests is witnessing significant growth due to increasing awareness about the importance of early detection and the rising prevalence of colorectal cancer worldwide. Governments, healthcare organizations, and advocacy groups are actively promoting colorectal cancer screening programs to reduce mortality rates and healthcare costs associated with late-stage diagnoses. Stool-based tests, such as fecal occult blood tests (FOBT) and fecal immunochemical tests (FIT), are gaining popularity due to their non-invasive nature and convenience for patients. Additionally, advancements in imaging technologies and blood-based biomarkers are improving the accuracy and efficacy of colorectal cancer screening tests. However, challenges such as patient compliance, access to screening facilities, and reimbursement issues hinder market growth. Nonetheless, with ongoing research and development efforts aimed at enhancing test accuracy, expanding screening programs, and improving patient awareness, the colorectal cancer screening test market is expected to continue growing, particularly in regions with aging populations and increasing healthcare infrastructure.
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Screening Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Screening Test.
Report Scope
The Colorectal Cancer Screening Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colorectal Cancer Screening Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Screening Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novigenix SA
Eiken Chemical Co., Ltd.
Clinical Genomics Pathology, Inc.
Exact Sciences Corporation
Epigenomics AG
BioMerieux S.A.
Olympus Corporation
Sysmex Corporation
Fujifilm Holdings Corporation
Siemens Healthineers AG (Siemens AG)
Segment by Type
Fecal Immunochemical Test (FIT)
Fecal Occult Blood Test (FOBT)
Stool-DNA Test
Other
Segment by Application
Hospitals & Clinics
Clinical Laboratories
Diagnostic Imaging Centres
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Screening Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Screening Test Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fecal Immunochemical Test (FIT)
1.2.3 Fecal Occult Blood Test (FOBT)
1.2.4 Stool-DNA Test
1.2.5 Other
1.3 Market by Application
1.3.1 Global Colorectal Cancer Screening Test Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals & Clinics
1.3.3 Clinical Laboratories
1.3.4 Diagnostic Imaging Centres
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Screening Test Market Perspective (2019-2030)
2.2 Colorectal Cancer Screening Test Growth Trends by Region
2.2.1 Global Colorectal Cancer Screening Test Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Colorectal Cancer Screening Test Historic Market Size by Region (2019-2024)
2.2.3 Colorectal Cancer Screening Test Forecasted Market Size by Region (2025-2030)
2.3 Colorectal Cancer Screening Test Market Dynamics
2.3.1 Colorectal Cancer Screening Test Industry Trends
2.3.2 Colorectal Cancer Screening Test Market Drivers
2.3.3 Colorectal Cancer Screening Test Market Challenges
2.3.4 Colorectal Cancer Screening Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Screening Test Players by Revenue
3.1.1 Global Top Colorectal Cancer Screening Test Players by Revenue (2019-2024)
3.1.2 Global Colorectal Cancer Screening Test Revenue Market Share by Players (2019-2024)
3.2 Global Colorectal Cancer Screening Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Screening Test Revenue
3.4 Global Colorectal Cancer Screening Test Market Concentration Ratio
3.4.1 Global Colorectal Cancer Screening Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Screening Test Revenue in 2023
3.5 Colorectal Cancer Screening Test Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Screening Test Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Screening Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Screening Test Breakdown Data by Type
4.1 Global Colorectal Cancer Screening Test Historic Market Size by Type (2019-2024)
4.2 Global Colorectal Cancer Screening Test Forecasted Market Size by Type (2025-2030)
5 Colorectal Cancer Screening Test Breakdown Data by Application
5.1 Global Colorectal Cancer Screening Test Historic Market Size by Application (2019-2024)
5.2 Global Colorectal Cancer Screening Test Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Colorectal Cancer Screening Test Market Size (2019-2030)
6.2 North America Colorectal Cancer Screening Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Colorectal Cancer Screening Test Market Size by Country (2019-2024)
6.4 North America Colorectal Cancer Screening Test Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Colorectal Cancer Screening Test Market Size (2019-2030)
7.2 Europe Colorectal Cancer Screening Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Colorectal Cancer Screening Test Market Size by Country (2019-2024)
7.4 Europe Colorectal Cancer Screening Test Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Screening Test Market Size (2019-2030)
8.2 Asia-Pacific Colorectal Cancer Screening Test Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Colorectal Cancer Screening Test Market Size by Region (2019-2024)
8.4 Asia-Pacific Colorectal Cancer Screening Test Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Screening Test Market Size (2019-2030)
9.2 Latin America Colorectal Cancer Screening Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Colorectal Cancer Screening Test Market Size by Country (2019-2024)
9.4 Latin America Colorectal Cancer Screening Test Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Screening Test Market Size (2019-2030)
10.2 Middle East & Africa Colorectal Cancer Screening Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Colorectal Cancer Screening Test Market Size by Country (2019-2024)
10.4 Middle East & Africa Colorectal Cancer Screening Test Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novigenix SA
11.1.1 Novigenix SA Company Detail
11.1.2 Novigenix SA Business Overview
11.1.3 Novigenix SA Colorectal Cancer Screening Test Introduction
11.1.4 Novigenix SA Revenue in Colorectal Cancer Screening Test Business (2019-2024)
11.1.5 Novigenix SA Recent Development
11.2 Eiken Chemical Co., Ltd.
11.2.1 Eiken Chemical Co., Ltd. Company Detail
11.2.2 Eiken Chemical Co., Ltd. Business Overview
11.2.3 Eiken Chemical Co., Ltd. Colorectal Cancer Screening Test Introduction
11.2.4 Eiken Chemical Co., Ltd. Revenue in Colorectal Cancer Screening Test Business (2019-2024)
11.2.5 Eiken Chemical Co., Ltd. Recent Development
11.3 Clinical Genomics Pathology, Inc.
11.3.1 Clinical Genomics Pathology, Inc. Company Detail
11.3.2 Clinical Genomics Pathology, Inc. Business Overview
11.3.3 Clinical Genomics Pathology, Inc. Colorectal Cancer Screening Test Introduction
11.3.4 Clinical Genomics Pathology, Inc. Revenue in Colorectal Cancer Screening Test Business (2019-2024)
11.3.5 Clinical Genomics Pathology, Inc. Recent Development
11.4 Exact Sciences Corporation
11.4.1 Exact Sciences Corporation Company Detail
11.4.2 Exact Sciences Corporation Business Overview
11.4.3 Exact Sciences Corporation Colorectal Cancer Screening Test Introduction
11.4.4 Exact Sciences Corporation Revenue in Colorectal Cancer Screening Test Business (2019-2024)
11.4.5 Exact Sciences Corporation Recent Development
11.5 Epigenomics AG
11.5.1 Epigenomics AG Company Detail
11.5.2 Epigenomics AG Business Overview
11.5.3 Epigenomics AG Colorectal Cancer Screening Test Introduction
11.5.4 Epigenomics AG Revenue in Colorectal Cancer Screening Test Business (2019-2024)
11.5.5 Epigenomics AG Recent Development
11.6 BioMerieux S.A.
11.6.1 BioMerieux S.A. Company Detail
11.6.2 BioMerieux S.A. Business Overview
11.6.3 BioMerieux S.A. Colorectal Cancer Screening Test Introduction
11.6.4 BioMerieux S.A. Revenue in Colorectal Cancer Screening Test Business (2019-2024)
11.6.5 BioMerieux S.A. Recent Development
11.7 Olympus Corporation
11.7.1 Olympus Corporation Company Detail
11.7.2 Olympus Corporation Business Overview
11.7.3 Olympus Corporation Colorectal Cancer Screening Test Introduction
11.7.4 Olympus Corporation Revenue in Colorectal Cancer Screening Test Business (2019-2024)
11.7.5 Olympus Corporation Recent Development
11.8 Sysmex Corporation
11.8.1 Sysmex Corporation Company Detail
11.8.2 Sysmex Corporation Business Overview
11.8.3 Sysmex Corporation Colorectal Cancer Screening Test Introduction
11.8.4 Sysmex Corporation Revenue in Colorectal Cancer Screening Test Business (2019-2024)
11.8.5 Sysmex Corporation Recent Development
11.9 Fujifilm Holdings Corporation
11.9.1 Fujifilm Holdings Corporation Company Detail
11.9.2 Fujifilm Holdings Corporation Business Overview
11.9.3 Fujifilm Holdings Corporation Colorectal Cancer Screening Test Introduction
11.9.4 Fujifilm Holdings Corporation Revenue in Colorectal Cancer Screening Test Business (2019-2024)
11.9.5 Fujifilm Holdings Corporation Recent Development
11.10 Siemens Healthineers AG (Siemens AG)
11.10.1 Siemens Healthineers AG (Siemens AG) Company Detail
11.10.2 Siemens Healthineers AG (Siemens AG) Business Overview
11.10.3 Siemens Healthineers AG (Siemens AG) Colorectal Cancer Screening Test Introduction
11.10.4 Siemens Healthineers AG (Siemens AG) Revenue in Colorectal Cancer Screening Test Business (2019-2024)
11.10.5 Siemens Healthineers AG (Siemens AG) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Colorectal Cancer Screening Test Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Fecal Immunochemical Test (FIT)
Table 3. Key Players of Fecal Occult Blood Test (FOBT)
Table 4. Key Players of Stool-DNA Test
Table 5. Key Players of Other
Table 6. Global Colorectal Cancer Screening Test Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Colorectal Cancer Screening Test Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Colorectal Cancer Screening Test Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Colorectal Cancer Screening Test Market Share by Region (2019-2024)
Table 10. Global Colorectal Cancer Screening Test Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Colorectal Cancer Screening Test Market Share by Region (2025-2030)
Table 12. Colorectal Cancer Screening Test Market Trends
Table 13. Colorectal Cancer Screening Test Market Drivers
Table 14. Colorectal Cancer Screening Test Market Challenges
Table 15. Colorectal Cancer Screening Test Market Restraints
Table 16. Global Colorectal Cancer Screening Test Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Colorectal Cancer Screening Test Market Share by Players (2019-2024)
Table 18. Global Top Colorectal Cancer Screening Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Screening Test as of 2023)
Table 19. Ranking of Global Top Colorectal Cancer Screening Test Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Colorectal Cancer Screening Test Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Colorectal Cancer Screening Test Product Solution and Service
Table 23. Date of Enter into Colorectal Cancer Screening Test Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Colorectal Cancer Screening Test Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Colorectal Cancer Screening Test Revenue Market Share by Type (2019-2024)
Table 27. Global Colorectal Cancer Screening Test Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Colorectal Cancer Screening Test Revenue Market Share by Type (2025-2030)
Table 29. Global Colorectal Cancer Screening Test Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Colorectal Cancer Screening Test Revenue Market Share by Application (2019-2024)
Table 31. Global Colorectal Cancer Screening Test Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Colorectal Cancer Screening Test Revenue Market Share by Application (2025-2030)
Table 33. North America Colorectal Cancer Screening Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Colorectal Cancer Screening Test Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Colorectal Cancer Screening Test Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Colorectal Cancer Screening Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Colorectal Cancer Screening Test Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Colorectal Cancer Screening Test Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Colorectal Cancer Screening Test Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Colorectal Cancer Screening Test Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Colorectal Cancer Screening Test Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Colorectal Cancer Screening Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Colorectal Cancer Screening Test Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Colorectal Cancer Screening Test Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Colorectal Cancer Screening Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Colorectal Cancer Screening Test Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Colorectal Cancer Screening Test Market Size by Country (2025-2030) & (US$ Million)
Table 48. Novigenix SA Company Detail
Table 49. Novigenix SA Business Overview
Table 50. Novigenix SA Colorectal Cancer Screening Test Product
Table 51. Novigenix SA Revenue in Colorectal Cancer Screening Test Business (2019-2024) & (US$ Million)
Table 52. Novigenix SA Recent Development
Table 53. Eiken Chemical Co., Ltd. Company Detail
Table 54. Eiken Chemical Co., Ltd. Business Overview
Table 55. Eiken Chemical Co., Ltd. Colorectal Cancer Screening Test Product
Table 56. Eiken Chemical Co., Ltd. Revenue in Colorectal Cancer Screening Test Business (2019-2024) & (US$ Million)
Table 57. Eiken Chemical Co., Ltd. Recent Development
Table 58. Clinical Genomics Pathology, Inc. Company Detail
Table 59. Clinical Genomics Pathology, Inc. Business Overview
Table 60. Clinical Genomics Pathology, Inc. Colorectal Cancer Screening Test Product
Table 61. Clinical Genomics Pathology, Inc. Revenue in Colorectal Cancer Screening Test Business (2019-2024) & (US$ Million)
Table 62. Clinical Genomics Pathology, Inc. Recent Development
Table 63. Exact Sciences Corporation Company Detail
Table 64. Exact Sciences Corporation Business Overview
Table 65. Exact Sciences Corporation Colorectal Cancer Screening Test Product
Table 66. Exact Sciences Corporation Revenue in Colorectal Cancer Screening Test Business (2019-2024) & (US$ Million)
Table 67. Exact Sciences Corporation Recent Development
Table 68. Epigenomics AG Company Detail
Table 69. Epigenomics AG Business Overview
Table 70. Epigenomics AG Colorectal Cancer Screening Test Product
Table 71. Epigenomics AG Revenue in Colorectal Cancer Screening Test Business (2019-2024) & (US$ Million)
Table 72. Epigenomics AG Recent Development
Table 73. BioMerieux S.A. Company Detail
Table 74. BioMerieux S.A. Business Overview
Table 75. BioMerieux S.A. Colorectal Cancer Screening Test Product
Table 76. BioMerieux S.A. Revenue in Colorectal Cancer Screening Test Business (2019-2024) & (US$ Million)
Table 77. BioMerieux S.A. Recent Development
Table 78. Olympus Corporation Company Detail
Table 79. Olympus Corporation Business Overview
Table 80. Olympus Corporation Colorectal Cancer Screening Test Product
Table 81. Olympus Corporation Revenue in Colorectal Cancer Screening Test Business (2019-2024) & (US$ Million)
Table 82. Olympus Corporation Recent Development
Table 83. Sysmex Corporation Company Detail
Table 84. Sysmex Corporation Business Overview
Table 85. Sysmex Corporation Colorectal Cancer Screening Test Product
Table 86. Sysmex Corporation Revenue in Colorectal Cancer Screening Test Business (2019-2024) & (US$ Million)
Table 87. Sysmex Corporation Recent Development
Table 88. Fujifilm Holdings Corporation Company Detail
Table 89. Fujifilm Holdings Corporation Business Overview
Table 90. Fujifilm Holdings Corporation Colorectal Cancer Screening Test Product
Table 91. Fujifilm Holdings Corporation Revenue in Colorectal Cancer Screening Test Business (2019-2024) & (US$ Million)
Table 92. Fujifilm Holdings Corporation Recent Development
Table 93. Siemens Healthineers AG (Siemens AG) Company Detail
Table 94. Siemens Healthineers AG (Siemens AG) Business Overview
Table 95. Siemens Healthineers AG (Siemens AG) Colorectal Cancer Screening Test Product
Table 96. Siemens Healthineers AG (Siemens AG) Revenue in Colorectal Cancer Screening Test Business (2019-2024) & (US$ Million)
Table 97. Siemens Healthineers AG (Siemens AG) Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Screening Test Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Colorectal Cancer Screening Test Market Share by Type: 2023 VS 2030
Figure 3. Fecal Immunochemical Test (FIT) Features
Figure 4. Fecal Occult Blood Test (FOBT) Features
Figure 5. Stool-DNA Test Features
Figure 6. Other Features
Figure 7. Global Colorectal Cancer Screening Test Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Colorectal Cancer Screening Test Market Share by Application: 2023 VS 2030
Figure 9. Hospitals & Clinics Case Studies
Figure 10. Clinical Laboratories Case Studies
Figure 11. Diagnostic Imaging Centres Case Studies
Figure 12. Others Case Studies
Figure 13. Colorectal Cancer Screening Test Report Years Considered
Figure 14. Global Colorectal Cancer Screening Test Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Colorectal Cancer Screening Test Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Colorectal Cancer Screening Test Market Share by Region: 2023 VS 2030
Figure 17. Global Colorectal Cancer Screening Test Market Share by Players in 2023
Figure 18. Global Top Colorectal Cancer Screening Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Screening Test as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Colorectal Cancer Screening Test Revenue in 2023
Figure 20. North America Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Colorectal Cancer Screening Test Market Share by Country (2019-2030)
Figure 22. United States Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Colorectal Cancer Screening Test Market Share by Country (2019-2030)
Figure 26. Germany Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Colorectal Cancer Screening Test Market Share by Region (2019-2030)
Figure 34. China Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Colorectal Cancer Screening Test Market Share by Country (2019-2030)
Figure 42. Mexico Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Colorectal Cancer Screening Test Market Share by Country (2019-2030)
Figure 46. Turkey Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Colorectal Cancer Screening Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Novigenix SA Revenue Growth Rate in Colorectal Cancer Screening Test Business (2019-2024)
Figure 49. Eiken Chemical Co., Ltd. Revenue Growth Rate in Colorectal Cancer Screening Test Business (2019-2024)
Figure 50. Clinical Genomics Pathology, Inc. Revenue Growth Rate in Colorectal Cancer Screening Test Business (2019-2024)
Figure 51. Exact Sciences Corporation Revenue Growth Rate in Colorectal Cancer Screening Test Business (2019-2024)
Figure 52. Epigenomics AG Revenue Growth Rate in Colorectal Cancer Screening Test Business (2019-2024)
Figure 53. BioMerieux S.A. Revenue Growth Rate in Colorectal Cancer Screening Test Business (2019-2024)
Figure 54. Olympus Corporation Revenue Growth Rate in Colorectal Cancer Screening Test Business (2019-2024)
Figure 55. Sysmex Corporation Revenue Growth Rate in Colorectal Cancer Screening Test Business (2019-2024)
Figure 56. Fujifilm Holdings Corporation Revenue Growth Rate in Colorectal Cancer Screening Test Business (2019-2024)
Figure 57. Siemens Healthineers AG (Siemens AG) Revenue Growth Rate in Colorectal Cancer Screening Test Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
